Plain-English translation of NCT04573283 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term health study for people diagnosed with metabolic associated fatty liver disease — a condition where fat builds up in the liver. Researchers want to collect samples from your blood, urine, and stool, and follow your health over time to find biological markers that can better predict how your disease will progress and help doctors care for patients like you.
Fatty liver disease affects many people but doctors don't yet have reliable ways to predict which patients will get worse and which will stay stable. This study aims to find biological signals in blood, urine, and stool samples that could help doctors understand the disease better and personalize treatment in the future.
You likely qualify if…
You likely don't qualify if…
You would visit the study center to have your medical information recorded and to donate samples of blood, urine, and stool. After that, researchers will follow your health over time, checking in with you regularly to see how you are doing and gathering more information about your condition. The study is being conducted in China and aims to enroll about 3,000 people total.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
China